Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.6.5 to v3.6.6, indicating a minor maintenance patch to the page. No study content or functionality changes are indicated by the provided data.SummaryDifference0.0%

- Check11 days agoChange DetectedA funding attribution line indicating NIH support was added to the study's identifiers. This addition provides provenance about funding for the trial.SummaryDifference0.0%

- Check18 days agoChange DetectedThree new publications were added to the Publications section, including comparative studies of efanesoctocog alfa versus emicizumab and versus standard/extended half-life FVIII, and a patient-satisfaction study from XTEND-1. These entries expand the peer-reviewed context for XTEND-1 without changing how the study is conducted or reported.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page adds a new release note: Revision: v3.6.5. Several minor footer/meta items are removed, including the EFC16293 Plain Language Results Summary, the Sanofi attribution line, the 'Helpful Links Provided by' section, and the older Revision: v3.6.4 reference, indicating a page cleanup.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4. This represents a page update to the document version, with no explicit user-facing content changes indicated.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 on the page, indicating a minor site version update. This change does not alter study data or content.SummaryDifference0.0%

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.